SCHEMBL18926239

SCHEMBL18926239

CCCC1(CCC(F)(F)F)c2ccccc2-c2ccc(C(=O)/C(=N/O)c3ccccc3C)cc21

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 20/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18838804 0.96 PDK2 (0.38) PDK2
SCHEMBL18838856 0.92 APEX1 (0.36) PDK2
SCHEMBL18812932 0.92 APEX1 (0.36) PDK2
SCHEMBL18812934 0.92 APEX1 (0.36) PDK2
SCHEMBL29368666 0.92 APEX1 (0.36) PDK2
SCHEMBL18926234 0.89 PDK2 (0.35) PDK2
SCHEMBL18123023 0.84 PDK2 (0.38) PDK2
SCHEMBL18926237 0.81 PDK2 (0.33) PDK2
SCHEMBL18123006 0.80 PDK2 (0.33) PDK2
SCHEMBL26443682 0.80 PDK2 (0.33) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170160636-A1 PHOTOSENSITIVE COMPOSITION AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170160636-A1 PHOTOSENSITIVE COMPOSITION AND COMPOUND C1R, CRY1, C1S PDK2 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback